Industry

In Other News

• Collaboration Brings Rapid At-Home STI Testing with Virtual Follow-Up

• Partnership Expands Ultrasensitive WGS Assay for for Hematologic Malignancies and MRD Monitoring

• QIAGEN Showcases Integrated Sample-to-Insight Oncology Solutions at AACR 2026

• Collaboration Applies AI Pathology to Predict Response to Antibody-Drug Conjugates

• Beckman Coulter Gains CE Mark for Rapid Assay Distinguishing Bacterial vs Viral Infections

• Junction, GRAIL Enable Scalable Access to Multi-Cancer Detection Test

• CE-Marked Blood Test Enables Monitoring of Neuroinflammation in Multiple Sclerosis

• FDA Clears At-Home HPV Test with Extended Genotyping for Cervical Screening

• GRAIL Partners with Epic to Integrate Multi-Cancer Test into EHR

• Global Partnership Aims to Streamline NGS Tumor Profiling in Oncology Trials

• Takara Bio USA and Hamilton Partner to Automate NGS Library Preparation

• Lunit and CellCarta Collaborate to Expand AI Pathology in CDx Development

• New CLIA Status Brings Mass Spectrometry Steroid Testing to Routine Labs

• First IVDR‑Certified IGH Clonality Assay Supports Diagnosis of B-Cell Malignancies

• Integrated DNA Technologies Expands into Clinical Diagnostics

• Co-Diagnostics Agreement Expands Commercial and Distribution Reach in South Asia

• Automated MSI Test Gains IVDR Certification to Guide CRC Therapy

• New Partnership Brings Alzheimer’s Blood Biomarker Test to Community Screening Network

• MGI Tech Strengthens Sequencing Portfolio with Dual Acquisition

• Agilent Technologies Acquires Pathology Diagnostics Company Biocare Medical

• Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparedness

• QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

• WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories